ESR1 and neoplasm: The American Society of Clinical Oncology (ASCO), and the College of American Pathologists (CAP) recommend that ER and PR assays be considered positive if the sample contains at least 1% positive tumor nuclei (fixed in 10% neutral buffered formalin) using the IHC method (104).